Plenary lecture

9:30 - 10:30 Cytosolic delivery of biotherapeutics: the struggle with biological barriers goes on
Stefaan de Smedt, University of Ghent, Belgium

10:30 - 11:00 Coffee / Exhibition / Posters

Invited talks: manufacturing equipment and technologies

11:00 - 11:40 Continuous drug product manufacturing - what does the future of pharmaceutical manufacturing looks like?
Giustino di Pretoro, Johnson & Johnson, Germany
11:40 - 12:20 Containment of highly potent compounds during manufacturing of solid dosage forms: in the past, at present and where will this all go to?
Iris Ziegler, Corden Pharma, Germany
12:20 - 13:00 The role of primary packaging in biotech drug stability: innovative solutions
Odra Pinato/Annalisa Delnevo, Stevanato Group, Italy

Short talks: Preformulation and Dermal/Transdermal

11:00 - 11:20 Enhancement of skin penetration of lipid-based nanocarriers
Coralie Bellefroid, University of Liege, Belgium
11:20 - 11:40 Glycosaminoglycans based scaffolds for wound healing
Giuseppina Sandri, University of Pavia, Italy
11:40 - 12:00 Development of Dissolving Microneedles for Delivery of Vancomycin Hydrochloride
Delly Ramadon, Queens University of Belfast, United Kingdom
12:00 - 12:20 Established and Innovative Buccal Dosage Forms Controlling Oromucosal Lidocaine Permeation
Diana Kottke, University of Düsseldorf, Germany
12:20 - 12:40 Oral self-emulsifying drug delivery system and intranasal nanoemulsions of phenytoin.
Isabel Moreira/Adriana Santos, University of Beira Interior, Portugal
12:40 - 13:00 High dose tobramycin dry powder inhaler: in vivo-in vitro dose emission
Francesca Buttini/Paolo Colombo, Unitersity of Parma/PlumeStars, Italy

13:00 - 15:00 Lunch / Exhibition / Posters

Invited talks: nanomedicines

15:00 - 15:40 New polymer-based drug delivery systems for cancer therapy
Julien Nicolas, University Paris-Sud, Fance
15:40 - 16:20 Drug product nanotechnologies: formulation and process aspects from laboratory to production plant
Paolo Gatti, Aptuit, Italy
16:20 - 17:00 Neurotrophic factor brain delivery for Parkinson's disease therapy
Maria José Blanco-Prieto, University of Navarra, Spain

Short talks: Oral Delivery

15:00 - 15:20 In vitro and in vivo assessment of different enabling approaches for oral delivery of fenofibrate
Ana Calduch-Arques/Anette Müllertz, University of Copenhagen, Denmark
15:20 - 15:40 Improved vitamin K uptake from orally administered mixed micelles under bile deficient conditions
Thijs Rooimans, University of Itrecht, Netherlands
15:40 - 16:00 A novel predictive dissolution method for establishing an IVIVC for contraceptive intravaginal rings
Katharina Tietz, University of Greifswald, Germany
16:00 - 16:20 The Manufacturing Classification System: Factors influencing process choices
Neil Dawson, Pfizer Worldwide Research & Development, United Kingdom
16:20 - 16:40 Lean and efficient development of a pseudoephedrine formulation resistant to conversion into meth
Isabella Immohr, Grünenthal GmbH, Germany
16:40 - 17:00 Solvent-induced phase separation during ASD preparation
Gabriele Sadowski, University of Dortmund, Germany

17:00 - 19:00 Welcome reception